SIRVs
The most comprehensive RNA spike-in controls
-
Ensure consistent quality of your experiments
-
Assess the performance and the limits of RNA-Seq workflows
-
Compatible with any organism and any platform
-
Free tool for SIRVs data evaluation
“”Integration of synthetic spike-ins SIRVs was particularly helpful when testing drugs that affect overall transcriptional output and thus cause a global decrease in mRNA levels.”
George Winter
PhD Principal Investigator, CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences
About Lexogen
Lexogen is a biotech company focusing on RNA and complete transcriptome studies using next generation sequencing technologies.
We have been at the forefront of RNA research since 2007, and our technologies and products are being used by thousands of scientists all over the world. “Lexo” in Greek means “word”, and Lexogen stands for the word of genes, which is the transcriptome. We strive to be the pioneers in this fascinating field of RNA science, and together with the fastest-growing technology of the past years, the next generation sequencing (NGS), we are sure that we can make a big contribution to the world.